AUG 6, 2026 · PHASE 3 TRIAL
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
ClinicalTrials.gov
This is a registry record of an ongoing Phase 3 trial with no results posted; the study is recruiting and outcomes have not yet been reported.
Reported
Planned enrollment800
PhasePhase 3
Primary outcome measureChange from baseline to Week 72 in Clinical…